Absci Corporation (ABSI)
NASDAQ: ABSI · IEX Real-Time Price · USD
4.20
-0.40 (-8.70%)
At close: Dec 29, 2023, 4:00 PM
4.21
+0.01 (0.24%)
After-hours: Dec 29, 2023, 7:56 PM EST
Absci Revenue
Absci had revenue of $6.94M in the twelve months ending September 30, 2023, with 22.95% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $744.00K, a -68.59% decrease year-over-year. In the year 2022, Absci had annual revenue of $5.75M with 20.18% growth.
Revenue (ttm)
$6.94M
Revenue Growth
+22.95%
P/S Ratio
56.27
Revenue / Employee
$35,943
Employees
193
Market Cap
390.34M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 5.75M | 965.00K | 20.18% |
Dec 31, 2021 | 4.78M | 2.00K | 0.04% |
Dec 31, 2020 | 4.78M | 2.72M | 132.04% |
Dec 31, 2019 | 2.06M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionABSI News
- 3 days ago - Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 11 days ago - Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline - GlobeNewsWire
- 27 days ago - Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate - GlobeNewsWire
- 4 weeks ago - AstraZeneca, AI biologics firm Absci tie up on cancer drug - FT - Reuters
- 6 weeks ago - Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results - GlobeNewsWire
- 6 weeks ago - Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases - Business Wire
- 2 months ago - Absci to Participate in Upcoming Investor Conferences - GlobeNewsWire